Author: Eric Sheetz

Major Drug Test Supplier To Stop Testing for Cannabis, Prioritize Fentanyl

A major supplier of drug testing kits has announced an updated screening panel which no longer tests for cannabis and prioritizes testing for fentanyl.  Psychemedics, a Massachusetts-based producer of drug testing kits announced Friday that they would be launching a new five-panel drug screen which will “[shift] the spotlight from marijuana to the paramount threat […]

Major Drug Test Manufacturer Replaces Marijuana With Fentanyl In Updated Screening Panel Amid Legalization Movement

A top manufacturer of drug testing technology has announced a new screening panel that no longer detects marijuana and instead prioritizes fentanyl and other controlled substances in response to the “relentless change and the pressing need to adapt” as more states legalize cannabis. Psychemedics said its updated Advanced 5-Panel Drug Screen “will transform the way […]

Swiss Dank Accounts: First Legal European Cannabis Dispensaries to Open in Switzerland

Switzerland will allow Europe’s first non-medical cannabis dispensaries to open and operate as part of a study to examine how controlled access to legal cannabis may affect health and consumption patterns of regular cannabis consumers. An announcement was made Friday about “Grashaus Projects” by German CBD and cannabinoid research company Sanity Group which said that […]

Report: Federal MJ Reform May Hurt Small Business and Equity, Congress Must Act

As states throughout the country continue to legalize medical and adult-use cannabis, the federal de-scheduling and later legalization of cannabis is likely to come sometime in the near future. But what exactly comes with such a widespread shift in policy? As we look ahead at the potential for federal legalization, a new report warns lawmakers […]

New Hampshire Panel Discusses Cannabis Legalization Recommendations

A New Hampshire cannabis panel, officially called the “Commission to Study With the Purpose of Proposing Legalization, State Controlled Sales of Cannabis and Cannabis Products,” held its most recent meeting after it was created this summer with the intention of presenting draft bill recommendations by Dec. 1, 2023. Legislators will discuss the recommendations next year […]

New York Cannabis Office Releases Fact Sheet To Battle Misinformation About Weed, Fentanyl

The New York Office of Cannabis Management (OCM) published a two-page report entitled “Cannabis and Fentanyl: Facts and Unknowns” to demystify the facts and myths of the two substances, specifically that of fentanyl contaminating cannabis. “The goal of this fact sheet is to provide evidence where it is available, to share information about what is […]

Denver Hits $500 Million Marijuana Tax Revenue Milestone, City Data Shows

Denver has achieved a new marijuana milestone, with adult-use and medical cannabis tax revenue now exceeding $500 million since 2010, city data released on Monday shows. As Colorado touts the fact that adult-use retailers have now sold more than $15 billion in marijuana products since legalization, the state’s largest city has released a report that […]

Eureka, CA Decriminalizes Psychedelic Plant Medicines

Eureka, CA, has passed a resolution decriminalizing entheogens and psychedelic plant medicines, making it the sixth California city to do so and the second such city in Humboldt County. The Eureka City Council unanimously approved an initiative last week to decriminalize plant medicines such as psilocybin mushrooms within city limits. The announcement came less than […]